Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1762096 | 0.85 | ALDH1A1 (0.49) | KMT2ASMN1; SMN2ALDH1A1HPGDLMNA | |
| SCHEMBL15176976 | 0.80 | L3MBTL1 (0.48) | KMT2ASMN1; SMN2ALDH1A1HPGDMAPT | |
| SCHEMBL13897310 | 0.80 | L3MBTL1 (0.43) | KMT2ASMN1; SMN2ALDH1A1HPGDLMNA | |
| SCHEMBL21098957 | 0.80 | L3MBTL1 (0.43) | KMT2ASMN1; SMN2ALDH1A1HPGDLMNA | |
| SCHEMBL4918493 | 0.78 | TRIM24 (0.41) | SMN1; SMN2MAPTALOX12 | |
| SCHEMBL27087460 | 0.78 | ALB (0.44) | KMT2ASMN1; SMN2ALOX12PPARAS1PR1 | |
| SCHEMBL7136952 | 0.78 | ALOX12 (0.43) | SMN1; SMN2HPGDMAPTALOX12LTA4H | |
| SCHEMBL6437142 | 0.77 | MAPT (0.41) | KMT2ASMN1; SMN2ALDH1A1HPGDMAPT | |
| SCHEMBL13939362 | 0.77 | MAPT (0.41) | KMT2ASMN1; SMN2ALDH1A1HPGDMAPT | |
| SCHEMBL18037724 | 0.77 | FURIN (0.44) | KMT2ASMN1; SMN2ALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12625144-B2 | Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule | Indian Institute Of Science Education And Research Bhopal (IN) | 2026-05-12 | — | — | US | disclosed |
| US-20220299521-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2022-09-22 | — | — | US | disclosed |
| WO-2020245843-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020245843-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2020-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220299521-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | PTMS, PA2G4, MAX | KMT2A 3541/4885SMN1; SMN2 3108/4885ALDH1A1 4707/4885 |
| US-12625144-B2 | Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule | DPYSL3, CD2BP2, PTMS | KMT2A 4121/4885SMN1; SMN2 3324/4885ALDH1A1 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.